Pre-Clinical CROs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Pre-Clinical CROs Market to 2027 - Global Analysis and Forecasts by Service (Bioanalysis & DMPK Studies, Toxicology Testing, and Others) End user (Biopharmaceutical Companies, Government & Academic Institutes, and Medical Device Companies) and Geography

Report Code: TIPRE00003316 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. Majority of the sponsoring organizations do not have the requisite facilities and staff for conducting tests under special supervision and appropriate set-up for particular drugs and medical devices and thus choose to contract research of this kind.

MARKET DYNAMICS
The pre-clinical CROs market is anticipated to grow in the forecast period owing to increasing budgets for early stage as well as rising adoption of outsourcing by pharmaceutical and medical device manufacturers. The market is likely to showcase opportunities for the new players with fastening drug and product approval procedures by the FDA and other regulatory bodies.

MARKET SCOPE
The "Global Pre-Clinical CROs Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of pre-clinical CROs market with detailed market segmentation by service, end user, and geography. The global pre-clinical CROs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pre-clinical CROs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global pre-clinical CROs market is segmented on the basis of service, and end user. Based on service, the market is segmented as bioanalysis & DMPK studies, toxicology testing, and others. On the basis of end user, the global pre-clinical CROs market is segmented in to biopharmaceutical companies, government & academic institutes, and medical device companies.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pre-clinical CROs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pre-clinical CROs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pre-clinical CROs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pre-clinical CROs market in these regions.

MARKET PLAYERS
The reports cover key developments in the pre-clinical CROs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from pre-clinical CROs market are anticipated to lucrative growth opportunities in the future with the rising demand for pre-clinical CROs market in the global market. Below mentioned is the list of few companies engaged in the pre-clinical CROs market.

The report also includes the profiles of key pre-clinical CROs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Envigo Corporation
  • Charles River
  • Eurofins Scientific
  • PRA Health Sciences, Inc
  • Wuxi AppTec
  • Medpace, Inc.
  • Pharmaceutical Product Development, LLC.
  • PAREXEL International Corporation
  • ICON plc
  • Laboratory Corporation of America Holdings
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Pre-Clinical CROs Market- By Service
1.3.2 Pre-Clinical CROs Market- By End User
1.3.3 Pre-Clinical CROs Market- By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PRE-CLINICAL CROS MARKET LANDSCAPE
4.1 MARKET OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis

5. PRE-CLINICAL CROS MARKET- KEY INDUSTRY DYNAMICS
5.1 KEY MARKET DRIVERS
5.2 KEY MARKET RESTRAINTS
5.3 KEY MARKET OPPORTUNITIES
5.4 FUTURE TRENDS
5.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PRE-CLINICAL CROS MARKET- GLOBAL ANALYSIS
6.1 PRE-CLINICAL CROS MARKET - GLOBAL MARKET OVERVIEW
6.2 PRE-CLINICAL CROS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3 MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. PRE-CLINICAL CROS MARKET REVENUE AND FORECASTS TO 2027 - SERVICE
7.1 OVERVIEW
7.2 SERVICE MARKET FORECASTS AND ANALYSIS
7.3 BIOANALYSIS & DMPK STUDIES MARKET
7.3.1 Overview
7.3.2 Bioanalysis & DMPK Studies Market Revenue Forecasts and Analysis (US$ Mn)
7.4 TOXICOLOGY TESTING MARKET
7.4.1 Overview
7.4.2 Toxicology Testing Market Revenue Forecasts and Analysis (US$ Mn)
7.5 OTHERS MARKET
7.5.1 Overview
7.5.2 Others Market Revenue Forecasts and Analysis (US$ Mn)

8. PRE-CLINICAL CROS MARKET REVENUE AND FORECASTS TO 2027 - END USER
8.1 OVERVIEW
8.2 END USER MARKET FORECASTS AND ANALYSIS
8.3 BIOPHARMACEUTICAL COMPANIES MARKET
8.3.1 Overview
8.3.2 Biopharmaceutical Companies Market Revenue Forecasts and Analysis (US$ Mn)
8.4 GOVERNMENT & ACADEMIC INSTITUTES MARKET
8.4.1 Overview
8.4.2 Government & Academic Institutes Market Revenue Forecasts and Analysis (US$ Mn)
8.5 MEDICAL DEVICE COMPANIES MARKET
8.5.1 Overview
8.5.2 Medical Device Companies Market Revenue Forecasts and Analysis (US$ Mn)

9. PRE-CLINICAL CROS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1 NORTH AMERICA PRE-CLINICAL CROS MARKET
9.1.1 North America Pre-Clinical CROs Market Forecasts and Analysis (US$ Mn)
9.1.2 North America Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.1.3 North America Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.1.4 North America Pre-Clinical CROs Market Forecasts and Analysis - By Country
9.1.5 US Market Overview
9.1.5.1 US Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.1.5.2 US Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.1.6 Canada Market Overview
9.1.6.1 Canada Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.1.6.2 Canada Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.1.7 Mexico Market Overview
9.1.7.1 Mexico Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.1.7.2 Mexico Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.2 EUROPE PRE-CLINICAL CROS MARKET
9.2.1 Europe Pre-Clinical CROs Market Forecasts and Analysis (US$ Mn)
9.2.2 Europe Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.2.3 Europe Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.2.4 Europe Pre-Clinical CROs Market Forecasts and Analysis - By Country
9.2.5 UK Market Overview
9.2.5.1 UK Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.2.5.2 UK Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.2.6 Germany Market Overview
9.2.6.1 Germany Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.2.6.2 Germany Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.2.7 France Market Overview
9.2.7.1 France Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.2.7.2 France Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.2.8 Italy Market Overview
9.2.8.1 Italy Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.2.8.2 Italy Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.2.9 Spain Market Overview
9.2.9.1 Spain Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.2.9.2 Spain Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.3 ASIA PACIFIC PRE-CLINICAL CROS MARKET
9.3.1 Asia Pacific Pre-Clinical CROs Market Forecasts and Analysis (US$ Mn)
9.3.2 Asia Pacific Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.3.3 Asia Pacific Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.3.4 Asia Pacific Pre-Clinical CROs Market Forecasts and Analysis - By Country
9.3.5 Japan Market Overview
9.3.5.1 Japan Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.3.5.2 Japan Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.3.6 India Market Overview
9.3.6.1 India Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.3.6.2 India Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.3.7 China Market Overview
9.3.7.1 China Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.3.7.2 China Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.3.8 South Korea Market Overview
9.3.8.1 South Korea Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.3.8.2 South Korea Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.3.9 Australia Market Overview
9.3.9.1 Australia Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.3.9.2 Australia Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.4 MIDDLE EAST & AFRICA (MEA) PRE-CLINICAL CROS MARKET
9.4.1 Middle East & Africa (MEA) Pre-Clinical CROs Market Forecasts and Analysis (US$ Mn)
9.4.2 Middle East & Africa (MEA) Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.4.3 Middle East & Africa Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.4.4 Middle East & Africa (MEA) Pre-Clinical CROs Market Forecasts and Analysis - By Country
9.4.5 South Africa Market Overview
9.4.5.1 South Africa Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.4.5.2 South Africa Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.4.6 Saudi Arabia Market Overview
9.4.6.1 Saudi Arabia Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.4.6.2 Saudi Arabia Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.4.7 UAE Market Overview
9.4.7.1 UAE Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.4.7.2 UAE Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.5 SOUTH AND CENTRAL AMERICA PRE-CLINICAL CROS MARKET
9.5.1 South and Central America Pre-Clinical CROs Market Forecasts and Analysis (US$ Mn)
9.5.2 South and Central America Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.5.3 South and Central America Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.5.4 South and Central America Pre-Clinical CROs Market Forecasts and Analysis - By Country
9.5.5 Brazil Market Overview
9.5.5.1 Brazil Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.5.5.2 Brazil Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)
9.5.6 Argentina Market Overview
9.5.6.1 Argentina Pre-Clinical CROs Market Forecasts and Analysis - By Service (US$ Mn)
9.5.6.2 Argentina Pre-Clinical CROs Market Forecasts and Analysis - By End User (US$ Mn)

10. INDUSTRY LANDSCAPE
10.1 ORGANIC GROWTH STRATEGIES
10.1.1 New Product Launches
10.1.2 Marketing & Promotional Activities
10.2 INORGANIC GROWTH STRATEGIES
10.2.1 Partnerships, Collaborations, and Joint Ventures
10.2.2 Mergers & Acquisitions

11. PRE-CLINICAL CROS MARKET, KEY COMPANY PROFILES
11.1 ENVIGO CORPORATION
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Service Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 CHARLES RIVER
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Service Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 EUROFINS SCIENTIFIC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Service Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 PRA HEALTH SCIENCES, INC
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Service Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 WUXI APPTEC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Service Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 MEDPACE, INC.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Service Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Service Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 PAREXEL INTERNATIONAL CORPORATION
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Service Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 ICON PLC
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Service Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 LABORATORY CORPORATION OF AMERICA HOLDINGS
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Service Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. APPENDIX
12.1 ABOUT THE INSIGHT PARTNERS
12.2 GLOSSARY OF TERMS
The List of Companies

1. Envigo Corporation
2. Charles River
3. Eurofins Scientific
4. PRA Health Sciences, Inc
5. Wuxi AppTec
6. Medpace, Inc.
7. Pharmaceutical Product Development, LLC.
8. PAREXEL International Corporation
9. ICON plc
10. Laboratory Corporation of America Holdings
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book